Literature DB >> 7259958

Combination therapy of a mouse sarcoma using razoxane and electron irradiation.

M B Grimshaw, R W Davies, W S Hall.   

Abstract

The combination of a single dose of razoxane (ICRF 159) with a single dose of electron radiation has been studied with the murine sarcoma S180. A drug dose of 30 mg/kg combined with radiation produced a greater tumour response than either agent alone, but it was not possible to establish whether the effect was more than additive. Direct measurements of tumour and s.c. oxygen concentrations and studies of tumour-cell respiration were carried out after various razoxane treatments in an attempt to elucidate mechanisms of action. There were no indications at the drug dose levels used in the radiation studies of any significant changes in tissue oxygenation or cellular respiration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259958      PMCID: PMC2010644          DOI: 10.1038/bjc.1981.156

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  An improved apparatus for the measurement of oxygen concentration.

Authors:  J R Roberts; H C Riddle; R W Davies
Journal:  Phys Med Biol       Date:  1975-07       Impact factor: 3.609

2.  Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.

Authors:  J Denekamp; S R Harris
Journal:  Radiat Res       Date:  1975-02       Impact factor: 2.841

3.  Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943).

Authors:  P J Creaven; M H Cohen; H H Hansen; O S Selawry; S G Taylor
Journal:  Cancer Chemother Rep       Date:  1974 May-Jun

4.  Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors.

Authors:  K Hellmann; G E Murkin
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

5.  Combined treatment of the Walker tumour with radiotherapy and ICRF 159.

Authors:  K Norpoth; A Schaphaus; H Ziegler; U Witting
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

6.  Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

7.  Oxygen cathodes for clinical measurements.

Authors:  R W Davies; W Hall
Journal:  Phys Med Biol       Date:  1973-03       Impact factor: 3.609

8.  Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159.

Authors:  L J Peters
Journal:  Br J Radiol       Date:  1976-08       Impact factor: 3.039

9.  Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line.

Authors:  I W Taylor; N M Bleehen
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

10.  The gross response of an experimental tumour to single doses of x-rays.

Authors:  R H Thomlinson; E A Craddock
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.